BPMC: Blueprint Medicines Corporation Stock

by  •  • Comments Off on BPMC: Blueprint Medicines Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6,029.53
Enterprise Value ($M) 6,569.66
Book Value ($M) 298.67
Book Value / Share 4.67
Price / Book 20.19
NCAV ($M) -138.47
NCAV / Share -2.17
Price / NCAV -43.54

Profitability (mra)
Return on Invested Capital (ROIC) -0.07
Return on Assets (ROA) -0.06
Return on Equity (ROE) -0.51

Liquidity (mrq)
Quick Ratio 2.80
Current Ratio 2.85

Balance Sheet (mrq) ($M)
Current Assets 742.68
Assets 1,179.81
Liabilities 881.15
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 508.82
Operating Income -212.04
Net Income -67.09
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -192.59
Cash from Investing -47.50
Cash from Financing 273.11

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Fmr Llc
11-14 13G/A Price T Rowe Associates Inc /md/ 8.50 -13.82
2024-02-08 13G/A Wellington Management Group Llp 7.03 -14.53
2024-01-24 13G/A BlackRock, Inc. 10.80 4.94

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-13 10-K UNITED STATES
2024-10-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 178,530 620,934 28.75
2025-02-20 198,221 626,487 31.64
2025-02-19 147,858 654,010 22.61
2025-02-18 182,414 1,087,049 16.78

(click for more detail)

Similar Companies
BLUE – bluebird bio, Inc. BMEA – Biomea Fusion, Inc.
BMRN – BioMarin Pharmaceutical Inc. CABA – Cabaletta Bio, Inc.
CCCC – C4 Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io